The Epigenetics of Testicular Germ Cell Tumors: Looking for Novel Disease Biomarkers
2017; Future Medicine; Volume: 9; Issue: 2 Linguagem: Inglês
10.2217/epi-2016-0081
ISSN1750-1911
AutoresAna Laura Costa, João Lobo, Cármen Jerónimo, Rui Henrique,
Tópico(s)Histone Deacetylase Inhibitors Research
ResumoTesticular germ cell tumors (TGCT) are a group of heterogeneous, biologically diverse and clinically challenging neoplasms. Despite the relatively low incidence and mortality rates, a subgroup of patients with disseminated disease relapse after conventional therapy and have a dismal prognosis. Moreover, TGCT afflict mostly young men and have therapeutic peculiarities, with some patients showing resistance to cisplatin-based treatments and others being troubled by irreversible side effects, such as infertility. Most TGCT share a common tumorigenic pathway and are cytogenetically similar, making room for Epigenetics to explain its heterogeneity at pathological and clinical level. In this review, we summarize the foremost epigenetic alterations among TGCT focusing on their clinical potential as diagnostic, prognostic and predictive biomarkers.
Referência(s)